A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma

Schroeder, Eric

142 - Scientific Plenary
A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma

Tuesday, March 25, 2014: 11:09 AM

Ballroom B/C (Tampa Convention Center)

E. D. Schroeder¹, J. De La Garza¹, A. E. Garcia-Soto², K. E. Hew¹, J. M. Pearson³, F. Simpkins⁴, J. A. Lucci III⁵, J. P. Diaz⁶, F. Andrade¹ and X. Burbano-Levy⁷
¹University of Miami-Jackson Memorial Hospital, Miami, FL, ²University of Miami Jackson Memorial Hospital, Miami, FL, ³University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, ⁴University of Miami, Miami, FL, ⁵University of Miami Miller School of Medicine, Miami, FL, ⁶South Miami Gynecologic Oncology Group, Miami, FL, ⁷Zilonis Health, Inc., Miami, FL

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

142 - Scientific Plenary
A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma

142 - Scientific Plenary A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma

142 - Scientific Plenary
A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma